Mirna McDonald

678 total citations
20 papers, 536 citations indexed

About

Mirna McDonald is a scholar working on Physiology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Mirna McDonald has authored 20 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 4 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Mirna McDonald's work include Asthma and respiratory diseases (12 papers), Eosinophilic Esophagitis (3 papers) and Migraine and Headache Studies (2 papers). Mirna McDonald is often cited by papers focused on Asthma and respiratory diseases (12 papers), Eosinophilic Esophagitis (3 papers) and Migraine and Headache Studies (2 papers). Mirna McDonald collaborates with scholars based in United States, Germany and Israel. Mirna McDonald's co-authors include David W. Smith, Philip M. Marden, Ian Civil, Margaret Garin, G.J. Creemers, Jaap Verweij, JHM Schellens, M de Boer-Dennert, B. E. Davies and Hilde Rosing and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, British Journal of Cancer and British Journal of Clinical Pharmacology.

In The Last Decade

Mirna McDonald

20 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirna McDonald United States 10 132 132 108 81 74 20 536
M. Castro Argentina 16 252 1.9× 119 0.9× 254 2.4× 77 1.0× 248 3.4× 26 1000
Toshihide Kubo Japan 17 178 1.3× 128 1.0× 57 0.5× 157 1.9× 56 0.8× 48 748
Ruth Bolier Netherlands 12 117 0.9× 50 0.4× 218 2.0× 31 0.4× 53 0.7× 17 744
P. J. Miach Australia 12 230 1.7× 61 0.5× 46 0.4× 54 0.7× 66 0.9× 24 571
Emmilia A. Dowlatshahi Netherlands 10 76 0.6× 81 0.6× 135 1.3× 16 0.2× 46 0.6× 12 978
Morteza Bagheri Iran 13 133 1.0× 70 0.5× 38 0.4× 22 0.3× 48 0.6× 64 629
Irma‐Leena Notkola Finland 8 371 2.8× 116 0.9× 103 1.0× 42 0.5× 50 0.7× 9 608
Karen E. Pedersen Australia 8 53 0.4× 123 0.9× 277 2.6× 119 1.5× 137 1.9× 12 625
Chrysanthi Sardeli Greece 16 130 1.0× 78 0.6× 101 0.9× 69 0.9× 127 1.7× 59 665
Rebecca Crawford United States 11 263 2.0× 38 0.3× 73 0.7× 39 0.5× 78 1.1× 29 602

Countries citing papers authored by Mirna McDonald

Since Specialization
Citations

This map shows the geographic impact of Mirna McDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirna McDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirna McDonald more than expected).

Fields of papers citing papers by Mirna McDonald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirna McDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirna McDonald. The network helps show where Mirna McDonald may publish in the future.

Co-authorship network of co-authors of Mirna McDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Mirna McDonald. A scholar is included among the top collaborators of Mirna McDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirna McDonald. Mirna McDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virchow, J. Christian, Mirna McDonald, Margaret Garin, & Stephanie Korn. (2020). Reslizumab as add-on therapy in patients with refractory asthma. BMJ Open Respiratory Research. 7(1). e000494–e000494. 10 indexed citations
2.
Virchow, J. Christian, Rohit Katial, Guy Brusselle, et al.. (2019). Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 540–548.e1. 29 indexed citations
3.
McDonald, Mirna, et al.. (2019). Effect of intravenously administered reslizumab on spirometric lung age in patients with moderate-to-severe eosinophilic asthma. Allergy and Asthma Proceedings. 40(4). 240–249. 2 indexed citations
4.
Bradbury, Margaret, Orit Cohen‐Barak, Igor D. Grachev, et al.. (2018). Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects. British Journal of Clinical Pharmacology. 84(10). 2422–2432. 31 indexed citations
5.
Singh, Rashmi B. Halker, Ernesto Aycardi, Marcelo E. Bigal, et al.. (2018). Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials. Cephalalgia. 39(1). 52–60. 24 indexed citations
6.
Weinstein, Steven F., Rohit Katial, Philip G. Bardin, et al.. (2018). Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps. The Journal of Allergy and Clinical Immunology In Practice. 7(2). 589–596.e3. 65 indexed citations
7.
Korenblat, Phillip E., Mirna McDonald, & Margaret Garin. (2018). Improvements In Individual Asthma Control Questionnaire (ACQ-5) Questions With Reslizumab In Patients With Inadequately Controlled Asthma and Elevated Blood Eosinophils: Pooled Analysis of Two Phase 3 Trials. Journal of Allergy and Clinical Immunology. 141(2). AB17–AB17. 1 indexed citations
8.
Castro, Mario, Yochai Adir, Pascal Chanez, et al.. (2018). Consistent efficacy across endpoints with reslizumab despite short term variability in blood eosinophil levels. PA1043–PA1043. 1 indexed citations
9.
Chanez, Pascal, Yochai Adir, Mario Castro, et al.. (2018). Intravenous (IV) reslizumab improves asthma control, symptoms, and quality of life in patients with historically elevated blood eosinophils. PA600–PA600. 1 indexed citations
10.
Silberstein, Stephen D., Alan M. Rapoport, Pippa S. Loupe, et al.. (2018). The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment. Headache The Journal of Head and Face Pain. 59(3). 383–393. 27 indexed citations
11.
Katial, Rohit, Flavia Hoyte, Matthew Germinaro, & Mirna McDonald. (2017). Efficacy of Reslizumab in Asthma Patients with Aspirin Sensitivity and Elevated Blood Eosinophils. Journal of Allergy and Clinical Immunology. 139(2). AB8–AB8. 3 indexed citations
12.
13.
Virchow, J. Christian, Margaret Garin, Mirna McDonald, & Roland Buhl. (2017). Clinically meaningful FEV1 response with reslizumab achieved early and sustained over 52 weeks. PA4690–PA4690. 1 indexed citations
14.
Wechsler, Michael E., Margaret Garin, Mirna McDonald, & Stephanie Korn. (2017). Reslizumab for uncontrolled eosinophilic asthma in patients who experienced a single exacerbation in the previous year: sub-analysis of two phase 3 trials. PA3960–PA3960. 1 indexed citations
15.
Carr, Warner, et al.. (2017). P223 Reslizumab improves spirometric lung age in patients with severe eosinophilic asthma. Annals of Allergy Asthma & Immunology. 119(5). S57–S57. 1 indexed citations
16.
Green, Justin A., Bela Patel, Azra Hussaini, et al.. (2014). Tafenoquine at therapeutic concentrations does not prolong fridericia‐corrected QT interval in healthy subjects. The Journal of Clinical Pharmacology. 54(9). 995–1005. 29 indexed citations
17.
Donnan, Peter T. & Mirna McDonald. (2009). Patients’ experiences of a diagnosis of Hughes’ syndrome. Clinical Rheumatology. 28(9). 1091–1100. 7 indexed citations
18.
Schellens, JHM, G.J. Creemers, Jos H. Beijnen, et al.. (1996). Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor. British Journal of Cancer. 73(10). 1268–1271. 113 indexed citations
19.
Civil, Ian & Mirna McDonald. (1978). Acute selenium poisoning: case report.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 87(612). 354–6. 39 indexed citations
20.
Marden, Philip M., David W. Smith, & Mirna McDonald. (1964). Congenital anomalies in the newborn infant, including minor variations. Nursing Research. 13(4). 361–361. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Castro Breakdown of academic impact, for papers by Toshihide Kubo Breakdown of academic impact, for papers by Ruth Bolier Breakdown of academic impact, for papers by P. J. Miach Breakdown of academic impact, for papers by Emmilia A. Dowlatshahi Breakdown of academic impact, for papers by Morteza Bagheri Breakdown of academic impact, for papers by Irma‐Leena Notkola Breakdown of academic impact, for papers by Karen E. Pedersen Breakdown of academic impact, for papers by Chrysanthi Sardeli Breakdown of academic impact, for papers by Rebecca Crawford
Rankless by CCL
2026